Shares of CoreWeave (CRWV +1.49%) jumped after the company filed an 8-K detailing a fresh order with Meta Platforms.
The agreement initially commits up to $14.2 billion of spend through Dec. 14, 2031, "with the option to materially expand its commitment through 2032 for additional cloud computing capacity"-- sending the GPU-cloud provider's stock higher as investors digested the scale and duration of the commitment. Shares climbed as much as 16.4%, but were up about 13% as of noon ET.
Image source: Getty Images.
Massive dealmaking
The new order sits under an existing master services agreement and provides Meta access to CoreWeave's reserved artificial intelligence (AI) compute capacity. In plain English, Meta is locking in a lot of high-end GPU cloud for years, with room to grow. That should help CoreWeave diversify beyond its biggest ecosystem relationships and improve revenue visibility through 2031, with a possible step-up in 2032. It also signals that hyperscale AI buyers continue to secure multiyear capacity, a trend that can move shares quickly when deals are disclosed.
Importantly, this Meta news comes just days after CoreWeave and OpenAI expanded their own agreement by up to $6.5 billion. That Sep. 25 update increased OpenAI's long-term commitments with CoreWeave and extended the relationship through 2031. Taken together, the two back-to-back announcements highlight how CoreWeave is steadily locking in multibillion-dollar, multiyear partnerships with the most important AI developers.
NASDAQ: CRWV
Key Data Points
Valuation and the long view
The business clearly has momentum -- and today's Meta order strengthens the backlog and diversifies demand. That said, after a string of headline contracts and a sharp rebound in the share price, the stock appears priced for perfection. We're talking about a cyclical company with a market capitalization of $68 billion that is still reporting losses.
Of course, we can't rule out a scenario in which fundamentals do exceed expectations. But this will depend on the speed of future capacity ramps and market demand over the next five years -- two very unpredictable factors.
Overall, in a capital-intensive, fast-moving market where supply chains, customer concentration, and hardware cycles can shift quickly, patience is probably a good idea. At a lower price, the stock might make sense. But after its recent run-up, it's probably worth staying on the sidelines.
